Pharmalex Nordic ApS: Financial statements 2024
CVR: 37541540
Source: annual report 2024, Danish Business Authority
01/10/2023 – 30/09/2024
Pharmalex Nordic ApS (CVR 37541540) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 4,083,048 and a net result of DKK -88,447,652. Equity in the 2024 report amounted to DKK -47,667,235. The company had 2 employees in the financial year.
- Gross Profit
- DKK 4,083,048
- Profit/Loss
- DKK -88,447,652
- Equity
- DKK -47,667,235
- Total Assets
- DKK 195,381,462
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 4.1M | -88.4M | -47.7M | 2 |
| 2022 | - | 3.3M | 1.4M | 34.5M | 2 |
| 2021 | - | 3.4M | 4.9M | 33.1M | 2 |
| 2020 | - | 2.6M | 3.6M | 28.2M | 2 |
| 2019 | - | 2.4M | 2.4M | 24.6M | 2 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of October 31, 2024, Laurent Maurice Robert Couston has stepped down as director of Pharmalex Nordic ApS.
As of October 1, 2024, Åsa Pihlblad is registered as adm. dir. of Pharmalex Nordic ApS.
As of October 1, 2024, Torben Thers Nørgaard has stepped down as adm. dir. of Pharmalex Nordic ApS.
Pharmalex Nordic ApS has published its interim report for the period January 1, 2023 to September 30, 2023.
About Pharmalex Nordic ApS
Pharmalex Nordic ApS is a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2016. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Åsa Pihlblad and Christopher Gauglitz. The company is owned by AmerisourceBergen International B.V.. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 3,533,803 and a net result of DKK 1,709,691 compared with DKK -88,447,652 the year before. Equity in the 2025 report amounted to DKK -45,957,544.